- Report
- April 2025
- 189 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 138 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 123 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2024
- 109 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- July 2024
- 97 Pages
Africa, Middle East
From €3140EUR$3,450USD£2,692GBP
- Report
- July 2024
- 114 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- July 2024
- 107 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2022
- 200 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- April 2024
- 450 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Clinical Trials
- February 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 120 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- July 2024
- 91 Pages
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 206 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- December 2023
- 155 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2023
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2023
- 121 Pages
Global
From €3500EUR$4,120USD£3,106GBP

Atropine Sulfate is a medication used to treat a variety of cardiovascular conditions, including bradycardia, heart block, and asystole. It is a synthetic anticholinergic drug, meaning it blocks the action of acetylcholine, a neurotransmitter that helps regulate heart rate. Atropine Sulfate is administered intravenously or intramuscularly, and is available in a variety of forms, including tablets, injections, and ophthalmic solutions. It is also used to treat certain types of poisoning, such as organophosphate poisoning.
Atropine Sulfate is widely used in the treatment of cardiovascular conditions, and is available from a variety of pharmaceutical companies. Some of the companies in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more